DFIs are well positioned to address five pressure points in the COVID-19 response that need financing. Let’s unpack these one by one.
CGD Policy Blogs
In 2019, major sources of concessional finance—the big global health funders like the Global Fund and Gavi, as well as the development-bank-based IDA and the African Development Fund—will ask donors for more money to accomplish more health and development.
From the superbug scare in Pennsylvania last month to the UK’s recently released Review on Antimicrobial Resistance, slowing the rate at which infections become resistant to antibiotics is rising up the list of global health priorities—and rightfully so. The Review estimates that deaths from antimicrobial resistance (AMR) could reach 10 million people a year by 2050 if we don’t reduce the overuse and misuse of antimicrobials, including antibiotics, and that the economic damage could add up to a staggering $100 trillion by 2050.